More on this book
Community
Kindle Notes & Highlights
Read between
March 22 - August 11, 2024
The US, with 4 percent of the world’s population, suffered 14.5 percent of total COVID deaths. By September 30, 2021, mortality rates in the US had climbed to 2,107/1,000,000, compared to 139/1,000,000 in Japan.
An August 2021 study by the Commonwealth Fund ranked America’s health care system dead last among industrialized nations, with the highest infant mortality and the lowest life expectancy.
Autism, which many scientists now consider an autoimmune disease,63,64,65 exploded from between 2/10,000 and 4/10,000 Americans66 when Tony Fauci joined NIAID, to one in thirty-four today.
In September 2021, former FDA Commissioner Dr. Scott Gotleib admitted that the six-foot distancing rule that Dr. Fauci and his HHS colleagues imposed upon Americans was “arbitrary,” and not, after all, science backed. The process for making that policy choice, Gotleib continued, “Is a perfect example of the lack of rigor around how CDC made recommendations.”
The public never received facts about infection fatality rates or age-stratified risks for COVID with the kind of clarity that might have allowed them and their physicians to make evidence-based personal risk assessments.
This is exactly what my MN data was!
Gallup polling showed that the average Democrat believed that 50 percent of COVID infections resulted in hospitalizations. The real number was less than one percent.
Telling people to “trust the experts” is either naive or manipulative—or both.
“Using repurposed drugs, we could have ended this pandemic by May 2020 and saved 500,000 American lives, but for Dr. Fauci’s hard-headed, tunnel vision on new vaccines and remdesivir.”
“By April and May, I noticed a disturbing trend,” recalls McCullough. “The trend was, no effort to treat patients who are infected with COVID-19 at home or in nursing homes. And it almost seemed as if patients were intentionally not being treated, allowed to sit at home and get to the point where they couldn’t breathe and then be admitted to the hospital.”
“We didn’t have a single academic institution come up with a single protocol,” said Dr. McCullough. “They didn’t even try. Harvard, Johns Hopkins, Duke, you name it. Not a single medical center set up even a tent to try to treat patients and prevent hospitalization and death. There wasn’t an ounce of original research coming out of America available to fight COVID—other than vaccines.” All of these universities are deeply dependent on billions of dollars that they receive from NIH.
“Never in the history of medicine,” says Dr. Cole, “has early treatment, of any patient with any disease, been so overtly neglected by the medical profession on such a massive scale.”
hydroxychloroquine (HCQ) and other therapeutics posed an existential threat to Dr. Fauci and Bill Gates’ $48 billion COVID vaccine project, and particularly to their vanity drug remdesivir, in which Gates has a large stake.
Under federal law, new vaccines and medicines cannot qualify for Emergency Use Authorization (EUA) if any existing FDA-approved drug proves effective against the same malady:
HCQ is the #1 most used medication in India, the second-most populous nation on the planet, with 1.3 billion people.
Prior to the COVID pandemic, HCQ and its progenitor, chloroquine (CQ), were freely available over the counter in most of the world, including France, Canada, Iran, Mexico, Costa Rica, Panama, and many other countries.
In the United States, the FDA has approved HCQ without limitation for 65 years, meaning that physicians can pre...
This highlight has been truncated due to consecutive passage length restrictions.
CDC study published in 2005 in the Virology Journal, “Chloroquine is a Potent Inhibitor of SARS Coronavirus Infection and Spread” demonstrated that CQ quickly eliminated coronavirus in primate cell culture during the SARS outbreak. That study concludes: “We report . . . that chloroquine has strong antiviral effects on SARS-Coronavirus infection of primate cells . . . [both] before or after exposure to the virus, suggesting both prophylactic and therapeutic advantage.”
their main trick for ensuring the protocols failed was to wait until late in the disease process before administering HCQ—when it is known to be ineffective. Dr. Risch noted that evidence against HCQ used late in the course of the disease is irrelevant.
The prospect of an existing therapeutic drug (with an expired patent) that could outperform any vaccine in the war against COVID posed a momentous threat to the pharmaceutical cartel.
On January 13, when rumors of Wuhan flu COVID-19 began to circulate, the French government took the bizarre, inexplicable, unprecedented, and highly suspicious step of reassigning HCQ from an over-the-counter to a prescription medicine.43 Without citing any studies, French health officials quietly changed the status of HCQ to “List II poisonous substance” and banned its over-the-counter sales.44 This absolutely remarkable coincidence repeated itself a few weeks later when Canadian health officials did the exact same thing, quietly removing the drug from pharmacy shelves.45
A physician from Zambia reported to Dr. Harvey Risch that in some villages and cities, organized groups of buyers emptied drugstores of HCQ and then burned the medication in bonfires outside the towns. South Africa destroyed two tons of life-saving hydroxychloroquine in late 2020, supposedly due to violation of an import regulation.46 The US government in 2021 ordered the destruction of more than a thousand pounds of HCQ, because it was improperly imported.
Once the FDA approves a prescription medication, federal laws allow any US physician to prescribe the duly approved drug for any reason.
Most pharmacists were afraid to dispense HCQ, and on June 15, state pharmacy boards in Arizona, Arkansas, Michigan, Minnesota, New Hampshire, New York, Oregon, and Rhode Island began refusing orders from physicians and retailers.
despite the fact that hygiene in those countries is often far inferior, in Ethiopia,127 Mozambique,128 Niger,129 Congo,130 and Ivory Coast,131 there are far fewer per capita deaths than in the US. In those nations, death rates vary between 8 and 47.2 deaths per million inhabitants as of September 24, 2021. In contrast, western countries that denied access to HCQ experienced numbers of coronavirus deaths per million inhabitants between 220 per million in Holland,132 2,000 per million in the US, and 850 deaths per million in Belgium.
An April 3, 2020 article entitled “Lab experiments show anti-parasitic drug, ivermectin, eliminates SARS-CoV-2 in cells in 48 hours,”6 by Australian researchers at Monash and Melbourne Universities and the Royal Melbourne Hospital, first won IVM global attention as a potential treatment for COVID.
In Argentina, for example, in the summer of 2020, Dr. Hector Carvallo conducted a randomized placebo-controlled trial of ivermectin as a preventative, finding 100 percent efficacy against COVID. Carvallo’s team found no infections among the 788 workers who took weekly ivermectin prophylaxis, whereas 58 percent of the 407 controls had become ill with COVID-19.
hospitalizations by almost 90 percent and deaths by almost 75 percent.” Kory is one of a multitude of leading front-line physicians, including McCullough, Florida’s Surgeon General Joe Ladopo, Professor Paul Marik, Dr. Joseph Varone, and mRNA vaccine inventor, Dr. Robert Malone, and many, many others, who believe that early treatment with ivermectin would have avoided 75 percent-80 percent of deaths and saved our country a trillion dollars in treasure.
NIH took extreme measures to keep the names secret, fighting all the way into federal court to shield the proceedings from transparency.32,33
Remdesivir cost Gilead $10 per dose to manufacture.18,19 But by granting Gilead an EUA, regulators could force private insurers, Medicare, and Medicaid to fork over around $3,120.00 per treatment—hundreds of times the cost of the drug.
In the WHO’s trial, remdesivir failed to reduce mortality, and failed to reduce the need for ventilators OR the length of hospital stays. WHO researchers found no detectable benefits from remdesivir and recommended against its use in COVID-19 patients.
“It makes no sense to give an antiviral in late stages of a viral infection,” Dr. Kory adds. “The viral replication mainly takes place prior to day seven. If an antiviral works, that’s when you administer antivirals. Remdesivir might work early on, but we don’t know, because it’s IV administered and you can’t really do that to ambulatory patients.”
Dr. McCullough gives us a stark and clear summary: “Remdesivir has two problems. First, it doesn’t work. Second, it is toxic and it kills people.”
Vaccines are one of the rare commercial products that multiply profits by failing.
Overwhelming science has proven that vaccinated and unvaccinated individuals are equally likely to spread disease.
Far more people died in the vaccine group than in the placebo group during Pfizer’s clinical trials.
fully vaccinated individuals from this age group experienced a 53 percent HIGHER reported infection rate than the unvaccinated that month. Rather than preventing cases, the vaccine may be enhancing transmission.
Just before I published this book, in late October 2021,
as Dr. Peter McCullough observed, “each vaccinated person is now a kind of Typhoid Mary for COVID, spreading concentrated viral loads of vaccine resistant mutants to vaccinated and unvaccinated alike.”
By the twentieth century, more people were dying of old age and heart attacks than from contagious illnesses.
Prior to 1997, the FDA forbade pharmaceutical advertising on television, and the drug companies had not yet transformed television reporters into pharmaceutical reps.
community doctors were achieving promising results with off-label therapeutic drugs that seemed effective against the constellation of symptoms that actually killed and tormented people with AIDS. These included off-the-shelf remedies like ribavirin, alpha interferon, DHPG, Peptide D, and Foscarnet for retinal herpes; and Bactrim, Septra, and aerosol pentamidine for AIDS-related pneumonias. Despite years of pleading by the HIV community, Dr. Fauci refused to test any of those repurposed drugs, which had older or expired patents and no Pharma patrons.11 One of the most promising of these
...more
At the time, AIDS was almost exclusive to intravenous drug users and males who had sex with other males, but Dr. Fauci incorrectly warned of “the possibility that routine close contact, as within a family household, can spread the disease.” Given that “nonsexual, non-blood-borne transmission is possible,” Fauci wrote, “the scope of the syndrome may be enormous.”
Dr. Fauci’s reflexive response was to amplify the widespread panic of dreaded pestilence that would naturally magnify his power, elevate his profile, and expand his influence. Amplifying terror of infectious disease was already an ingrained knee-jerk institutional response at NIAID.
In 1987, the Wall Street Journal won a Pulitzer Prize for its investigation of an HHS scheme its writers characterized as a deliberate campaign by officials to misrepresent AIDS as a general pandemic to secure greater public funding and financial support.
His laser focus on a single magic bullet antiviral left Dr. Fauci reluctant to study drugs that treated the constellations of grim infections that tortured and killed people with AIDS; patient care—which typically involved off-the-shelf drugs—was incompatible with NIAID’s mushrooming mercantile obsession with high-price patented antivirals.
He told them that the treatment experiences and voluminous case study reports of dozens of community AIDS doctors was not real science. The activists were aware of this increasingly lethal irony: It had been NIAID’s decision to not fund any randomized trials on these unpatented drugs. Dr. Fauci himself had constructed this dead end. This pattern of resourceful stonewalling to obstruct repurposed off-patent drugs with lifesaving potential would become a pattern familiar to Dr. Fauci’s critics during the COVID crisis.
The choice, he explained, of which compounds would enter NIAID’s clinical trial pipeline was made, not by public agreement, but by a panel of “independent scientists.” Dr. Fauci did not mention that virtually all the members of his “independent panel” were pharmaceutical PIs, with ties to NIAID and Burroughs Wellcome.
Rep. Pelosi asked Dr. Fauci to assume that he had AIDS and found himself dying of pneumonia: “You know the theory behind aerosol pentamidine to prevent pneumonia is strong. You know that the aerosol pentamidine was evaluated by the NIH as highly promising. You know that many studies in San Francisco recommend it routinely and that it is available. . . . Would you take aerosol pentamidine or would you wait for a study?”56 For three years, Dr. Fauci had done everything in his power to deny aerosol pentamidine and its companion drug, Bactrim, to AIDS sufferers. But here’s what he told the panel
...more
Thirty-two years later, Dr. Fauci performed an encore of this kabuki dance during the early COVID crisis. On March 24, 2020, he answered a question from a journalist by admitting that, if he became ill with COVID, he would take hydroxychloroquine as his remedy.
Just as he would do with hydroxychloroquine during the COVID crisis thirty years later, he designed his AL 721 clinical trials in a way that would ensure their failure and thus discredit the unpatentable medicine.
